Danaher (DHR) Q4 2024 Annual Earnings
DHR·Reported January 29, 2025·Before market open
Danaher reported Q4 2024 revenue of $6.5B, beat analyst consensus of $6.4B by $92.6M. Diluted EPS came in at $2.14. Danaher reports across 3 business segments, led by Diagnostics, Biotechnology, and Life Sciences.
Revenue
$6.5Bbeat by $92.6M
Consensus: $6.4BDiluted EPS
$2.14met estimate
Consensus: $2.14
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Danaher's Q4 2024 earnings report.
Danaher (DHR) reported Q4 2024 earnings on January 29, 2025 before market open.
Danaher reported revenue of $6.5B and diluted EPS of $2.14 for Q4 2024.
Revenue beat the consensus estimate of $6.4B by $92.6M. EPS beat the consensus estimate of $2.14 by $0.00.
You can read the 10-K periodic report (0000313616-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.